Abstract CT240: IOB-032/PN-E40: A phase 2 study of neoadjuvant/adjuvant IO102-IO103 cancer vaccine plus pembrolizumab in resectable HNSCC
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Barbara Burtness, Ravindra Uppaluri, Michael J. Dennis, Annette M. Lim, Richard A. Scolyer, Erin Alesi, Ayako Wakatsuki Pedersen, Amy Wesa, Ravi K. Adapala, Ulla Kring Hansen, Marcos Iglesias, Bushi Wang, Cecilie Abildgaard, Qasim Ahmad, Francois Ringeisen, Georgina V. Long, Robert I. Haddad
Institutions: Yale Cancer Center, Yale University, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, The University of Melbourne, Peter MacCallum Cancer Centre, The University of Sydney, Royal Prince Alfred Hospital, NSW Health Pathology, VCU Massey Comprehensive Cancer Center, Melanoma Institute Australia
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154745970
Cites:
Cited by:
Related to: